About this item:

736 Views | 449 Downloads

Author Notes:

Corresponding Author: Frank A. Anania, MD, FACP, AGAF Associate Professor of Medicine Director of Hepatology Division of Digestive Diseases, Department of Medicine Emory University School of Medicine 615 Michael Street Suite 201, Room 248 Atlanta, GA 30322 Phone: 404-712-2867 Facsimile: 404-712-2980 fanania@emory.edu

These authors contributed equally to this work

AUTHOR CONTRIBUTION:Jeffrey Handy participated in all aspects of this work.

Ping Fu and Pradeep Kumar contributed to the execution of the experiments and acquisition of data.

Jamie Mells participated in the design of the experiments and interpretation of data. Shvetank Sharma participated in interpretation of data and manuscript preparation.

Neeraj Saxena and Frank Anania participated in experimental design, data interpretation and manuscript preparation.

ACKNOWLEDGEMENT: The authors wish to thank Dr. Martin Myers at the University of Michigan for his generous sharing of the anti-phospho Jak2 (Ser523) anti sera.

Subject:

Research Funding:

Supported by (R24)DK064399, (R01)DK062092, (R01)DK075397 and (K08) DK076742

Keywords:

  • Fibrosis
  • Adiponectin
  • Leptin
  • SOCS-3
  • PTP1B
  • Jak2

Adiponectin inhibits leptin signaling via multiple mechanisms to exert protective effects against hepatic fibrosis

Tools:

Journal Title:

Biochemical Journal

Volume:

Volume 440, Number 3

Publisher:

, Pages 385-395

Type of Work:

Article | Post-print: After Peer Review

Abstract:

SYNOPSIS Adiponectin is protective against hepatic fibrosis, while leptin promotes fibrosis. In hepatic stellate cells (HSCs), leptin signals via a Janus Kinase 2/Signal Transducers and Activators of Transcription 3 (Jak2/Stat3) pathway, producing effects that enhance extracellular matrix deposition. Suppressors of Cytokine Signaling-3 (SOCS-3) and Protein Tyrosine Phosphatase-1B (PTP1B) are both negative regulators of Jak/Stat signaling, and recent studies demonstrated a role for adiponectin in regulating SOCS-3 expression. In this study we investigated mechanisms whereby adiponectin dampens leptin signaling and prevents excess ECM production. We treated culture-activated rat HSCs with recombinant adiponectin, leptin, both or neither, and also treated adiponectin knockout (Ad−/−) and wild-type mice with leptin and/or carbon tetrachloride (CCl4), or saline. We analyzed Jak2 and Ob-Rb phosphorylation, and PTP1B expression and activity. We also explored potential mechanisms through which adiponectin regulates SOCS-3/Ob-Rb association. Adiponectin inhibited leptin-stimulated Jak2 activation and Ob-Rb phosphorylation in HSCs, while both were increased in Ad−/− mice. Adiponectin stimulated PTP1B expression and activity, in vitro, while PTP1B expression was lower in Ad−/−mice than in wild-type mice. Adiponectin also promoted SOCS-3/Ob-R association, and blocked leptin-stimulated formation of extracellular TIMP-1/MMP-1 complexes, in vitro. These data suggest two novel mechanisms whereby adiponectin inhibits hepatic fibrosis: by promoting binding of SOCS-3 to Ob-Rb, and stimulating PTP1B expression and activity, thus inhibiting Jak2-Stat3 signaling at multiple points.

Copyright information:

© 2011 Portland Press Limited

Export to EndNote